First cut is the deepest: paper on incisional hernia sliced for duplication

jamcolsurgeonsThe authors of a 2014 paper in the Journal of the American College of Surgeons about incisional hernia have lost their article for being a duplicate submission.

The paper, “Impact on Quality of Life of Using an Onlay Mesh to Prevent Incisional Hernia in Midline Laparotomy: A Randomized Clinical Trial,” came from a group at the Parc Tauli University Hospital, part of the Universitat Autònoma de Barcelona, in Spain.

By duplicating another paper, the authors (three of which appear to be listed on both papers) committed “a severe abuse of the scientific publishing system,” according to the retraction notice: Continue reading First cut is the deepest: paper on incisional hernia sliced for duplication

Publisher and uni go head to head over disputed images in diabetes papers

Mario Saad, via unicamp.br
Mario Saad, via unicamp.br

The State University of Campinas University of Campinas and the American Diabetes Association disagree strongly over how to handle disputed images from faculty member Mario Saad, who is suing the ADA to prevent retraction of his papers.

While the State University of Campinas University of Campinas (Unicamp) acknowledges that 2 of Saad’s papers contain “mistakes”, it concluded there was “not an intention in the actions of the authors,” and the mistakes did not have a negative impact on the scientific community. Ultimately: “the studies published have their own strength, are healthy and were not artificially strengthened by the incorrect images.”

In response, however, Saad’s lawsuit says the ADA asked the school to reinvestigate the articles, and refused to accept any papers from Unicamp faculty in any ADA journals until the issues are resolved.

The ADA has issued four expressions of concern in Saad’s research published in its flagship journal, Diabetes. Saad’s lawsuit aims to prevent the journal from retracting those papers, and asks for monetary compensation.

Retraction Watch has obtained a report of the investigation by Unicamp and Saad’s lawsuit. You can read the full lawsuit here, and the investigation report here.

Here is an excerpt from the Unicamp’s findings: Continue reading Publisher and uni go head to head over disputed images in diabetes papers

Math paper subtracted for plagiarism

Screen Shot 2015-02-10 at 1.02.16 PMISPACS’ Journal of Nonlinear Analysis and Application, whose website promises “very fast publication,” has pulled a paper for ripping off an article posted on arXiv.org.

Their plagiarism wasn’t exactly subtle. Here’s the abstract from the paper on arXiv.org:

We introduce and study the class of weak almost limited operators. We establish a characterization of pairs of Banach lattices E, F for which every positive weak almost limited operator T:EF is almost limited (resp. almost Dunford-Pettis). As consequences, we will give some interesting results.

And here’s the abstract from the retracted paper:

Continue reading Math paper subtracted for plagiarism

Chem paper retracted because “a significant amount of data” was wrong

Jced_coverThe editors of ACS’s Journal of Chemical and Engineering Data have sunk a paper on halogenated alkanes after realizing that “a significant amount” of the data was “inaccurate,” thereby “invalidating” the paper.

Here’s the notice for “Influence of Solvent Nature on the Solubility of Halogenated Alkanes” (which has only been cited twice, according to Google Scholar): Continue reading Chem paper retracted because “a significant amount of data” was wrong

“FDA has repeatedly hidden evidence of scientific fraud,” says author of new study

jama int medFor decades, the U.S. FDA has uncovered misconduct in clinical trials but hidden it from the public, according to a new paper in JAMA Internal Medicine.

The study, by New York University journalism professor Charles Seife, looked at 78 publications resulting from trials where the FDA found serious misconduct, including “failure to protect the safety of patients” and data fakery. Only three of those publications mentioned the problems uncovered by the FDA. No retractions or errata were ever issued for any of them.

For example, in one of the three cases: Continue reading “FDA has repeatedly hidden evidence of scientific fraud,” says author of new study

Figure dupe sinks cell bio paper

cellular biohemTulane researchers Tong Wu and Chang Han, who have been anonymously accused of figure duplication in the past, have now finally lost a paper for that reason.

The frequent plagiarism tipster Juuichi Jigen (a pseudonym) set up a blog in 2012 alleging that the pair inappropriately reused images in six other papers, though none of those have been retracted. The recent notice, issued at the end of January by the Journal of Cellular Biochemistry, states that the figure duplication was confirmed by the University of Pittsburgh’s Office of Research Integrity. Han, the first author, was at UPitt when the paper was published in 2008, though she moved to join Wu at Tulane in 2009.

Here’s the notice for “Regulation of Wnt/ß-Catenin Pathway by cPLA2α and PPARδ“: Continue reading Figure dupe sinks cell bio paper

Diabetes researcher sues journal to prevent retractions of papers cited more than 600 times

Mario Saad, via unicamp.br
Mario Saad, via unicamp.br

Mario A. Saad, who last year retracted a paper for plagiarism, is now suing the American Diabetes Association over four expressions of concern in its flagship journal, Diabetes.

As reported in the Boston Business Journal, Saad’s lawsuit claims that his institution, the State University of Campinas, investigated two articles at the journal’s behest. The American Diabetes Association was unhappy with the results, and asked the school to reopen the investigation, including two additional papers.

Saad is suing to prevent the journal from retracting the papers, in addition to monetary compensation.

Continue reading Diabetes researcher sues journal to prevent retractions of papers cited more than 600 times

Heart study bleeds into three papers, one retracted and one withdrawn

janWith the increasingly hectic pace of modern life, everybody is always on the look out for time-saving tricks and tips.

Scientists at the National University of Singapore and the Hong Kong Polytechnic University certainly found one, but we really can’t recommend it: doing one randomized controlled trial (RCT) with several outcomes, and publishing them as three separate 2014 papers with “considerable overlap.”

So far, one paper has been retracted, and another withdrawn.

Continue reading Heart study bleeds into three papers, one retracted and one withdrawn

Fourth retraction appears for cancer researcher Anil Jaiswal

cancer research 1113The hits keep coming for University of Maryland researcher Anil Jaiswal.

The latest retraction for the cell biologist is in Cancer Research, for a 2007 paper about ways in which the cell tries to protect the tumor suppressor p53. Like the first Jaiswal retraction we covered, the latest notice specifically taps figure duplication as the cause of death, “as a result of an error.” The other two retractions gave no explanation for the withdrawal.

Here’s the notice: Continue reading Fourth retraction appears for cancer researcher Anil Jaiswal

He shoots, he…misses! Soccer injury paper gets red card for data errors

jsmsThe authors of a 2014 paper on soccer injuries have forfeited their publication after revealing that the foundation of the work was based on faulty data. (Look, we could have written about letting air out of balls, yadda yadda, but the Super Bowl has come and gone.)

The article, which appeared in the Journal of Science and Medicine in Sport, was written by a group in Denmark and Qatar led by Cristiano Eirale, a sports medicine researcher at the Aspetar-Qatar Orthopedic and Sports Medicine Hospital, in Doha. It showed goalies had a lower rate of injuries during training than field players.

Trouble was, someone called a foul.

Continue reading He shoots, he…misses! Soccer injury paper gets red card for data errors